Journal of Cardiovascular Pharmacology and Therapeutics
Editor: Robert A. Kloner, MD, PhD Heart Institute, Good Samaritan Hospital, Los Angeles; Keck School of Medicine, University of Southern California, Los Angeles
Description:

Submit your article online with SAGETRACK!

SAGETRACK makes it easy to:

  • Submit your article online
  • Submit revisions and resubmissions through automatic linking
  • Track the progress of your article online
  • Publish faster with JCPT!

Visit http://mc.manuscriptcentral.com/jcpat




This journal offers optional funded open access. Click here for more information.

Call for Papers

DON'T MISS A BEAT!

Every informative issue of the Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as:

    • Agents that Reduce Myocardial Infarct Size
    • Agents that Reduce Myocardial Remodeling
    • Angiotensin Converting Enzyme Inhibitors
    • Antihypertensive Therapy
    • Arrhythmias
    • Atrial Fibrillation
    • Beta-Blocker Therapies
    • Cardioembolic Stroke
    • Cardiomyopathy
    • Cardioprotective Agents
    • Cardiopulmonary Resuscitation
    • Cardiovascular Combination Therapies
    • Chronic Angina
    • Chronic Cardiac Ischemia
    • Congestive Heart Failure
    • Coronary Artery Disease
    • Coronary Revascularization
    • Heparin Therapies
    • Hypertension
    • Hypotension
    • Implantable Devices
    • Ischemic Heart Disease
    • Myocardial Infarction
    • Percutaneous Coronary Interventions
    • Peripheral Arterial Disease
    • Preconditioning/Postconditioning
    • Regenerative Cardiology
    • Stem Cell Therapy

Among the drug classes regularly evaluated are: ACE inhibitors * angiotensin receptor blockers * anti-anginals * anti-arrhythmics * anti-coagulants * anti-hypertensives * anti-thrombins * beta-blockers * calcium channel blockers * cardioprotective agents * cardiotonic agents * direct renin inhibitors * diuretics * fibrinolytic agents * heart rate modulats * plasminogen activators * QT prolonging drugs * statins * vasoconstrictor agents * and vasodilator agents.

The journal features original articles, topical journal supplements, reviews, clinical and experimental investigations, and commentaries written by respected practitioners from all over the world.

SUBSCRIBE TODAY!

Thomson Reuters 2008 Journal Citation Reports®

2008 Ranking:

48/78 in Cardiac and Cardiovascular Systems
141/216 in Pharmacology & Pharmacy

2008 Impact Factor: 1.672

Subscription Information:
Institutional Subscription, Combined (Print & E-access) $779.00
Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content) $857.00
Institutional Subscription, E-access $701.00
Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content) $779.00
Institutional Backfile Purchase, E-access (Content through 1998) $701.00
Institutional Subscription, Print Only $763.00
Hospital Subscription, Combined (Print & E-access) $514.00
Individual Subscription, Combined (Print & E-access) $295.00

Individual articles are available for immediate purchase online (See View Full-Text icon above). Print copies of individual issues can be purchased by contacting the SAGE Journals Customer Service department journals@sagepub.com 1-800-818-7243.

If you are eligible for non-standard pricing please contact Journals Customer Service department journals@sagepub.com 1-800-818-7243 for a price quote.
Institutional, Single Print Issue $210.00
Individual, Single Print Issue $96.00
Frequency: Quarterly eISSN: 1940-4034 ISSN: 1074-2484
Months of Distribution: March , June , September , December Current Volume: 14 Current Issue: 4
Other Titles In: Health Sciences  | Pharmacology  | Cardiology